Boston Scientific to Participate in 2018 Canaccord Genuity Medical Technologies & Diagnostics Forum

MARLBOROUGH, Mass., Nov. 7, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in the 2018 Canaccord Genuity Medical Technologies & Diagnostics Forum on Thursday, November 15, 2018 in New York City.

David Pierce, executive vice president and president, MedSurg and Susie Lisa, vice president, Investor Relations, will participate in a 60-minute roundtable discussion session with the host analyst beginning at approximately 9:30 a.m. EST. A live webcast of the session will be available on the Investor Relations section of the Boston Scientific website at investors.bostonscientific.com.

A replay of the webcast will be accessible at investors.bostonscientific.comhttp://www.bostonscientific.com/investors beginning approximately one hour following the completion of the event.

About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 35 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.

     
              CONTACTS



     Media:                           
     Investors:



     Kate Haranis                     
     Susie Lisa, CFA



     508-683-6585 (office)            
     508-683-5565 (office)



     Media Relations                  
     Investor Relations



     Boston Scientific Corporation    
     Boston Scientific Corporation



     
              Kate.Haranis@bsci.com 
     
              BSXInvestorRelations@bsci.com

View original content:http://www.prnewswire.com/news-releases/boston-scientific-to-participate-in-2018-canaccord-genuity-medical-technologies--diagnostics-forum-300745456.html

SOURCE Boston Scientific Corporation